Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Comparison of 3D printed prostate models with standard radiological information to aid understanding of the precise location of prostate cancer: A construct validation study.

Ebbing J, Jäderling F, Collins JW, Akre O, Carlsson S, Höijer J, Olsson MJ, Wiklund PN.

PLoS One. 2018 Jun 25;13(6):e0199477. doi: 10.1371/journal.pone.0199477. eCollection 2018.

2.

[Osteonecrosis of the jaws (ONJ) associated to antiresorptive treatment].

Larsson Wexell C, Kjellman A, Akre O.

Lakartidningen. 2018 May 25;115. pii: E394. Swedish.

3.

Concordance of Non-Low-Risk Disease Among Pairs of Brothers With Prostate Cancer.

Jansson F, Drevin L, Frisell T, Stattin P, Bratt O, Akre O.

J Clin Oncol. 2018 Jun 20;36(18):1847-1852. doi: 10.1200/JCO.2017.76.6907. Epub 2018 Apr 13.

PMID:
29652556
4.

Time-to-event Outcomes in Men with Nonmetastatic Castrate-resistant Prostate Cancer-A Systematic Literature Review and Pooling of Individual Participant Data.

Aly M, Hashim M, Heeg B, Liwing J, Leval A, Mehra M, Lawson J, Brookman-May SD, Akre O.

Eur Urol Focus. 2018 Apr 4. pii: S2405-4569(18)30088-9. doi: 10.1016/j.euf.2018.03.010. [Epub ahead of print] Review.

PMID:
29627197
5.

Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer.

Nordström T, Akre O, Aly M, Grönberg H, Eklund M.

Prostate Cancer Prostatic Dis. 2018 Apr;21(1):57-63. doi: 10.1038/s41391-017-0024-7. Epub 2017 Dec 19.

PMID:
29259293
6.

Cannabis Use and Incidence of Testicular Cancer: A 42-Year Follow-up of Swedish Men between 1970 and 2011.

Callaghan RC, Allebeck P, Akre O, McGlynn KA, Sidorchuk A.

Cancer Epidemiol Biomarkers Prev. 2017 Nov;26(11):1644-1652. doi: 10.1158/1055-9965.EPI-17-0428.

7.

Effect of Comorbidity on Prostate Cancer-Specific Mortality: A Prospective Observational Study.

Rajan P, Sooriakumaran P, Nyberg T, Akre O, Carlsson S, Egevad L, Steineck G, Wiklund NP.

J Clin Oncol. 2017 Nov 1;35(31):3566-3574. doi: 10.1200/JCO.2016.70.7794. Epub 2017 Sep 20.

8.

Nationwide, population-based study of post radical prostatectomy urinary incontinence correction surgery.

Ventimiglia E, Folkvaljon Y, Carlsson S, Bratt O, Montorsi F, Volz D, Akre O, Johansson E, Stattin P.

J Surg Oncol. 2018 Feb;117(2):321-327. doi: 10.1002/jso.24816. Epub 2017 Sep 6.

9.

Oncologic Outcomes After Robot-assisted Radical Prostatectomy: A Large European Single-centre Cohort with Median 10-Year Follow-up.

Rajan P, Hagman A, Sooriakumaran P, Nyberg T, Wallerstedt A, Adding C, Akre O, Carlsson S, Hosseini A, Olsson M, Egevad L, Wiklund F, Steineck G, Wiklund NP.

Eur Urol Focus. 2016 Nov 2. pii: S2405-4569(16)30154-7. doi: 10.1016/j.euf.2016.10.007. [Epub ahead of print]

PMID:
28753802
10.

Survival Among Men at High Risk of Disseminated Prostate Cancer Receiving Initial Locally Directed Radical Treatment or Initial Androgen Deprivation Therapy.

Sooriakumaran P, Nyberg T, Akre O, Widmark A, Hamdy F, Graefen M, Carlsson S, Steineck G, Wiklund NP.

Eur Urol. 2017 Sep;72(3):345-351. doi: 10.1016/j.eururo.2017.04.002. Epub 2017 Apr 14.

PMID:
28416350
11.

Family History and Probability of Prostate Cancer, Differentiated by Risk Category: A Nationwide Population-Based Study.

Bratt O, Drevin L, Akre O, Garmo H, Stattin P.

J Natl Cancer Inst. 2016 Jul 10;108(10). pii: djw110. doi: 10.1093/jnci/djw110. Print 2016 Oct.

PMID:
27400876
12.

Prediction of clinical progression after radical prostatectomy in a nationwide population-based cohort.

Bjartell A, Bottai M, Persson J, Bratt O, Damber JE, Stattin P, Akre O.

Scand J Urol. 2016 Aug;50(4):255-9. doi: 10.1080/21681805.2016.1183226. Epub 2016 May 18.

PMID:
27192553
13.

Postoperative mortality 90 days after robot-assisted laparoscopic prostatectomy and retropubic radical prostatectomy: a nationwide population-based study.

Björklund J, Folkvaljon Y, Cole A, Carlsson S, Robinson D, Loeb S, Stattin P, Akre O.

BJU Int. 2016 Aug;118(2):302-6. doi: 10.1111/bju.13404. Epub 2016 Feb 15.

14.

External validation of models predicting the individual risk of metachronous peritoneal carcinomatosis from colon and rectal cancer.

Segelman J, Akre O, Gustafsson UO, Bottai M, Martling A.

Colorectal Dis. 2016 Apr;18(4):378-85. doi: 10.1111/codi.13219.

PMID:
26588669
15.

Robotic networks: delivering empowerment through integration.

Collins J, Akre O, Challacombe B, Karim O, Wiklund P.

BJU Int. 2015 Aug;116(2):167-8. doi: 10.1111/bju.13032. No abstract available.

16.

Selective intraoperative cholangiography and risk of bile duct injury during cholecystectomy.

Törnqvist B, Strömberg C, Akre O, Enochsson L, Nilsson M.

Br J Surg. 2015 Jul;102(8):952-8. doi: 10.1002/bjs.9832. Epub 2015 Apr 28.

PMID:
25919401
17.

Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer.

Bratt O, Folkvaljon Y, Hjälm Eriksson M, Akre O, Carlsson S, Drevin L, Franck Lissbrant I, Makarov D, Loeb S, Stattin P.

Eur Urol. 2015 Jul;68(1):53-8. doi: 10.1016/j.eururo.2014.12.026. Epub 2015 Mar 23.

18.

Causes of death in men with localized prostate cancer: a nationwide, population-based study.

Van Hemelrijck M, Folkvaljon Y, Adolfsson J, Akre O, Holmberg L, Garmo H, Stattin P.

BJU Int. 2016 Mar;117(3):507-14. doi: 10.1111/bju.13059. Epub 2015 May 15.

19.

Physical activity and body mass index as predictors of prostate cancer risk.

Grotta A, Bottai M, Adami HO, Adams SA, Akre O, Blair SN, Mariosa D, Nyrén O, Ye W, Stattin P, Bellocco R, Trolle Lagerros Y.

World J Urol. 2015 Oct;33(10):1495-502. doi: 10.1007/s00345-014-1464-5. Epub 2015 Jan 4.

PMID:
25557943
20.

Acquired Hypothyroidism as a Predictive Marker of Outcome in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors: A Literature-Based Meta-Analysis.

Nearchou A, Valachis A, Lind P, Akre O, Sandström P.

Clin Genitourin Cancer. 2015 Aug;13(4):280-6. doi: 10.1016/j.clgc.2014.10.002. Epub 2014 Oct 24.

PMID:
25442773
21.

Fathering of dizygotic twins and risk of prostate cancer: nationwide, population-based case-control study.

Wirén S, Drevin L, Akre O, Robinson D, Stattin P.

PLoS One. 2014 Oct 22;9(10):e110506. doi: 10.1371/journal.pone.0110506. eCollection 2014.

22.

Maternal and pregnancy characteristics and risk of infantile hypertrophic pyloric stenosis.

Svenningsson A, Svensson T, Akre O, Nordenskjöld A.

J Pediatr Surg. 2014 Aug;49(8):1226-31. doi: 10.1016/j.jpedsurg.2014.01.053. Epub 2014 Feb 10.

PMID:
25092081
23.

Re: Walter Artibani, Vincenzo Ficarra, Ben J. Challacombe, et al. EAU policy on live surgery events. Eur urol 2014;66:87-97.

Collins JW, Akre O, Wiklund PN.

Eur Urol. 2014 Dec;66(6):e121-2. doi: 10.1016/j.eururo.2014.07.009. Epub 2014 Jul 24. No abstract available.

PMID:
25065527
24.

Authors' reply to Roach.

Sooriakumaran P, Nyberg T, Akre O, Steineck G, Wiklund P.

BMJ. 2014 Mar 25;348:g2271. doi: 10.1136/bmj.g2271. No abstract available.

PMID:
24668778
25.

Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes.

Sooriakumaran P, Nyberg T, Akre O, Haendler L, Heus I, Olsson M, Carlsson S, Roobol MJ, Steineck G, Wiklund P.

BMJ. 2014 Feb 26;348:g1502. doi: 10.1136/bmj.g1502.

26.

Individualized prediction of risk of metachronous peritoneal carcinomatosis from colorectal cancer.

Segelman J, Akre O, Gustafsson UO, Bottai M, Martling A.

Colorectal Dis. 2014 May;16(5):359-67. doi: 10.1111/codi.12552.

PMID:
24410859
27.

The impact of length and location of positive margins in predicting biochemical recurrence after robot-assisted radical prostatectomy with a minimum follow-up of 5 years.

Sooriakumaran P, Ploumidis A, Nyberg T, Olsson M, Akre O, Haendler L, Egevad L, Nilsson A, Carlsson S, Jonsson M, Adding C, Hosseini A, Steineck G, Wiklund P.

BJU Int. 2015 Jan;115(1):106-13. doi: 10.1111/bju.12483.

28.

Mortality following hip fracture in men with prostate cancer.

Van Hemelrijck M, Garmo H, Michaëlsson K, Thorstenson A, Akre O, Stattin P, Holmberg L, Adolfsson J.

PLoS One. 2013 Sep 27;8(9):e74492. doi: 10.1371/journal.pone.0074492. eCollection 2013.

29.

Risk of in-hospital complications after radical cystectomy for urinary bladder carcinoma: population-based follow-up study of 7608 patients.

van Hemelrijck M, Thorstenson A, Smith P, Adolfsson J, Akre O.

BJU Int. 2013 Dec;112(8):1113-20. doi: 10.1111/bju.12239. Epub 2013 Jul 26.

30.

Assessing catheter-associated urinary tract infection.

Akre O, Thulin H, Bottai M.

Lancet. 2013 May 4;381(9877):1535. doi: 10.1016/S0140-6736(13)60972-1. No abstract available.

PMID:
23642692
31.

Congenital malformations and testicular germ cell tumors.

Trabert B, Zugna D, Richiardi L, McGlynn KA, Akre O.

Int J Cancer. 2013 Oct 15;133(8):1900-4. doi: 10.1002/ijc.28207. Epub 2013 May 15.

32.

Risk of oesophageal adenocarcinoma among individuals born preterm or small for gestational age.

Forssell L, Cnattingius S, Bottai M, Edstedt Bonamy AK, Lagergren J, Agréus L, Akre O.

Eur J Cancer. 2013 Jun;49(9):2207-13. doi: 10.1016/j.ejca.2013.02.014. Epub 2013 Mar 13. Erratum in: Eur J Cancer. 2013 Oct;49(15):3385. Lina, Forssell [corrected to Forssell, Lina]; Sven, Cnattingius [corrected to Cnattingius, Sven]; Matteo, Bottai [corrected to Bottai, Matteo]; Anna-Karin, Edstedt Bonamy [corrected to Edstedt Bonamy, Anna-Karin]; Jesper, Lagergren [corrected to Lagergren,.

PMID:
23490653
33.

Increased risk of Barrett's esophagus among individuals born preterm or small for gestational age.

Forssell L, Cnattingius S, Bottai M, Edstedt Bonamy AK, Lagergren J, Agréus L, Akre O.

Clin Gastroenterol Hepatol. 2013 Jul;11(7):790-4. doi: 10.1016/j.cgh.2013.01.024. Epub 2013 Feb 1.

PMID:
23376800
34.

Fatherhood status and risk of prostate cancer: nationwide, population-based case-control study.

Wirén SM, Drevin LI, Carlsson SV, Akre O, Holmberg EC, Robinson DE, Garmo HG, Stattin PE.

Int J Cancer. 2013 Aug 15;133(4):937-43. doi: 10.1002/ijc.28057. Epub 2013 Mar 8.

35.

Obstructive pulmonary disease in old age among individuals born preterm.

Broström EB, Akre O, Katz-Salamon M, Jaraj D, Kaijser M.

Eur J Epidemiol. 2013 Jan;28(1):79-85. doi: 10.1007/s10654-013-9761-7. Epub 2013 Jan 23.

PMID:
23341027
36.

How can we make cancer survival statistics more useful for patients and clinicians: an illustration using localized prostate cancer in Sweden.

Eloranta S, Adolfsson J, Lambert PC, Stattin P, Akre O, Andersson TM, Dickman PW.

Cancer Causes Control. 2013 Mar;24(3):505-15. doi: 10.1007/s10552-012-0141-5. Epub 2013 Jan 8.

PMID:
23296456
37.

Treatment with finasteride and prostate cancer survival.

Kjellman A, Friis S, Granath F, Gustafsson O, Sørensen HT, Akre O.

Scand J Urol. 2013 Aug;47(4):265-71. doi: 10.3109/00365599.2012.737366. Epub 2012 Nov 9.

PMID:
23137166
38.

Thromboembolic events following surgery for prostate cancer.

Van Hemelrijck M, Garmo H, Holmberg L, Bill-Axelson A, Carlsson S, Akre O, Stattin P, Adolfsson J.

Eur Urol. 2013 Feb;63(2):354-63. doi: 10.1016/j.eururo.2012.09.041. Epub 2012 Sep 24.

PMID:
23021972
39.

Risk of esophagitis among individuals born preterm or small for gestational age.

Forssell L, Cnattingius S, Bottai M, Lagergren J, Ekbom A, Akre O.

Clin Gastroenterol Hepatol. 2012 Dec;10(12):1369-75. doi: 10.1016/j.cgh.2012.09.014. Epub 2012 Sep 16.

PMID:
22989864
40.

Self-perceived penile shortening after radical prostatectomy.

Carlsson S, Nilsson AE, Johansson E, Nyberg T, Akre O, Steineck G.

Int J Impot Res. 2012 Sep;24(5):179-84. doi: 10.1038/ijir.2012.13. Epub 2012 May 10.

PMID:
22573233
41.

Long-term valacyclovir suppressive treatment after herpes simplex virus type 2 meningitis: a double-blind, randomized controlled trial.

Aurelius E, Franzen-Röhl E, Glimåker M, Akre O, Grillner L, Jorup-Rönström C, Studahl M; HSV-2 Meningitis Study Group.

Clin Infect Dis. 2012 May;54(9):1304-13. doi: 10.1093/cid/cis031. Epub 2012 Mar 28. Erratum in: Clin Infect Dis. 2012 Aug;55(3):478.

PMID:
22460966
42.

Incidence of fractures causing hospitalisation in prostate cancer patients: results from the population-based PCBaSe Sweden.

Thorstenson A, Bratt O, Akre O, Hellborg H, Holmberg L, Lambe M, Bill-Axelson A, Stattin P, Adolfsson J.

Eur J Cancer. 2012 Jul;48(11):1672-81. doi: 10.1016/j.ejca.2012.01.035. Epub 2012 Mar 3.

PMID:
22386317
43.

Concordance of tumor differentiation among brothers with prostate cancer.

Jansson KF, Akre O, Garmo H, Bill-Axelson A, Adolfsson J, Stattin P, Bratt O.

Eur Urol. 2012 Oct;62(4):656-61. doi: 10.1016/j.eururo.2012.02.032. Epub 2012 Feb 24.

PMID:
22386193
44.

Perinatal risk factors for childhood testicular germ-cell cancer: a Nordic population-based study.

Stephansson O, Wahnström C, Pettersson A, Sørensen HT, Tretli S, Gissler M, Troisi R, Akre O, Grotmol T.

Cancer Epidemiol. 2011 Dec;35(6):e100-4. doi: 10.1016/j.canep.2011.07.003. Epub 2011 Aug 16. Erratum in: Cancer Epidemiol. 2012 Jun;36(3):327.

PMID:
21846595
45.

Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe Sweden.

Akre O, Garmo H, Adolfsson J, Lambe M, Bratt O, Stattin P.

Eur Urol. 2011 Sep;60(3):554-63. doi: 10.1016/j.eururo.2011.05.047. Epub 2011 Jun 1.

PMID:
21664039
46.

Screening for prostate cancer: defining critical issues.

Holmberg L, Akre O.

Acta Oncol. 2011 Jun;50 Suppl 1:2-3. doi: 10.3109/0284186X.2010.529459. No abstract available.

PMID:
21604933
47.

Cancer risk in hyperprolactinemia patients: a population-based cohort study.

Berinder K, Akre O, Granath F, Hulting AL.

Eur J Endocrinol. 2011 Aug;165(2):209-15. doi: 10.1530/EJE-11-0076. Epub 2011 May 20.

PMID:
21602317
48.

Celiac disease is not a risk factor for infertility in men.

Zugna D, Richiardi L, Akre O, Stephansson O, Ludvigsson JF.

Fertil Steril. 2011 Apr;95(5):1709-13.e1-3. doi: 10.1016/j.fertnstert.2011.01.132. Epub 2011 Feb 21.

PMID:
21333987
49.

Cancer risk in mothers of men operated for undescended testis.

Lacerda HM, Richiardi L, Pettersson A, Corbin M, Merletti F, Akre O.

PLoS One. 2010 Dec 10;5(12):e14285. doi: 10.1371/journal.pone.0014285.

50.

Soluble urokinase plasminogen activator receptor as a prognostic marker in men participating in prostate cancer screening.

Kjellman A, Akre O, Gustafsson O, Høyer-Hansen G, Lilja H, Norming U, Piironen T, Törnblom M.

J Intern Med. 2011 Mar;269(3):299-305. doi: 10.1111/j.1365-2796.2010.02284.x. Epub 2010 Dec 8.

Supplemental Content

Support Center